Epinephrine and Dexamethasone as Adjuvants in Upper Extremity Peripheral Nerve Blocks in Pediatric Patients

Ljubica Mikjunovikj-Derebanova1, Andrijan Kartalov1,2, Biljana Kuzmanovska1,2

  • 1University Clinic for Anesthesiology, Reanimation and Intensive Care Medicine, University "St Cyril and Methodius", Skopje, R.N. Macedonia.

Insights

Epinephrine and dexamethasone extend the duration of peripheral nerve blocks in children. Dexamethasone significantly prolonged sensory and motor block effects, reducing postoperative analgesic needs in pediatric patients.

Area of Science:

  • Pediatric Anesthesiology
  • Regional Anesthesia
  • Pharmacology

Background:

  • Regional anesthesia is increasingly accepted in pediatric care, aided by ultrasonography.
  • Adjuvants are crucial for prolonging local anesthetic effects and limiting cumulative doses.
  • Research on adjuvants for pediatric peripheral nerve blocks is ongoing.

Purpose of the Study:

  • To evaluate the efficacy of epinephrine and dexamethasone as adjuvants in pediatric upper extremity peripheral nerve blocks.
  • To compare the duration of sensory and motor blocks with these adjuvants.

Main Methods:

  • A randomized study of 63 pediatric patients (4-14 years) undergoing upper limb surgery.
  • Three groups received supraclavicular or interscalene blocks with lidocaine and bupivacaine.
  • Group 1: local anesthetic only; Group 2: with epinephrine; Group 3: with dexamethasone.

Main Results:

  • The control group had an average sensory block of 7 hours and motor block of 5.5 hours.
  • Epinephrine slightly prolonged block duration by approximately 30 minutes.
  • Dexamethasone significantly extended both sensory and motor block durations (p<0.0001).

Conclusions:

  • Both epinephrine and dexamethasone prolong the action of local anesthetics in pediatric upper extremity nerve blocks.
  • Dexamethasone demonstrates a significant and superior prolonging effect.
  • These adjuvants reduce the requirement for postoperative analgesics in pediatric patients.

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.1K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
402
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
632
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
618
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.1K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
515